WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Colon Cancer efficacy endpoints v5 20151112, Adjuvant or Neoadjuvant Treatment instantiated by - Yes - No, New lesion identified by Organ specific lesion ID, Repeated concepts/instances throughout the CMAP are denoted by dotted outline, Patient Characteristics include Performance Status Rating, Colo-rectal Cancer Stage instantiated by - 0 - I - II - III - IV, Objective Response Rate (ORR) correlates with Liver Metastases Resection Rate, Immunohistochemistry has outcome - Negative - Positive - Other, OVERALL RESPONSE have response options - CR - PR, Disease free survival (DFS) provides evidence for Disease recurrence, Non-measurable lesions evaluated by Existing lesion, Risk Features include ????, -Complete Response (CR) -Partial Response (PR) -Not all evaluated -Stable disease (SD) -Progressive disease (PD) summarized into OVERALL RESPONSE, Risk Features include Number of lymph nodes resected, Lesion has type Measurable lesions, Prior Therapy include Non surgical Liver-directed therapy, Short axis for target lymph nodes measured in mm, OVERALL RESPONSE have response options -CR -PR, Concepts are denoted by solid round-edged rectangle, Systemic represneted by - Oxaliplatin - Irinotecan - Anti-VEGF antibody - Anti-EGFR - Regorafenib - FP - TAS-102 - Other, Palliative Intent ???? OS PFS ORR